Astellas, Poseida Announce Investment To Support Poseida's Commitment To Cancer Cell Therapy

Astellas Pharma Gets Positive CHMP Opinion For XTANDI In Early Prostate Cancer Treatment Setting

Astellas Pharma Inc. announced Friday the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending approval of XTANDI (enzalutamide) as monotherapy or in combination with androgen deprivation therapy for the treatment of adult men with high risk biochemical recurrent (BCR) non-metastatic hormone sensitive prostate cancer (nmHSPC) who are unsuitable for salvage radiotherapy.

RTTNews | 404 days ago

Merck Says Phase 3 KEYNOTE-A39/EV-302 Trial Meets Dual Primary Endpoints

Merck & Co Inc. (MRK), known as MSD outside of the U.S. and Canada, announced Friday positive topline results from the Phase 3 KEYNOTE-A39 trial, which was conducted in collaboration with Seagen Inc. (SGEN) and Astellas Pharma Inc. (ALPMY.PK, ALPMY).

RTTNews | 586 days ago

Canadian Dollar Extends Gain Against Majors

The Canadian dollar extended gains against its major counterparts in the New York session on Wednesday.

RTTNews | 1h 43min ago

Pound Falls Against Most Majors

The pound weakened against its most major counterparts in the New York session on Wednesday.

RTTNews | 3h 12min ago

Swiss Market Ends On Positive Note

The Switzerland market, which held firm till well past noon on Wednesday after a steady start, suffered a setback in the final hour, but managed to recover in the closing minutes to sign off on a positive note. Easing worries about tariffs and some strong results helped underpin sentiment.

RTTNews | 4h 17min ago

Major European Markets Close Higher As Investors React To Earnings, Economic Data

The major European markets closed higher on Wednesday amid easing trade tensions, and on largely encouraging quarterly results from several big name companies. Investors also digested a slew of regional economic data, and U.S. GDP report.

RTTNews | 4h 46min ago

TSX Down Nearly 1% Despite Coming Off Early Lows

Despite staging a fairly strong recovery after an early setback, the Canadian market remains firmly down in negative territory a little past noon on Wednesday, with stocks from energy, technology and healthcare sectors reeling under selling pressure. Disappointing Canadian and U.S. GDP data, and Trump administration's policy uncertainty are weighing on sentiment.

RTTNews | 5h 30min ago

German Inflation At 6-Month Low, Core Figure Accelerates First Time In 4 Months

Germany's consumer price inflation slowed for a second straight month in April to its lowest level in six months as energy prices continued to fall, but the core price growth accelerated for the first time since December as services cost growth increased, which warrants caution from the European Central Bank that is set to reduce interest rates further.

RTTNews | 5h 40min ago

EURUSD	1.13252	GBPUSD	1.3324	AUDUSD	0.64016
USDJPY	142.934	USDCAD	1.37922	USDCHF	0.82619

Advertisement

Astellas, Poseida Announce Investment To Support Poseida's Commitment To Cancer Cell Therapy